ArticleProbiotics and antimicrobial proteins2026
Porcine Beta Defensin 2 Alleviates Apoptosis and Restores Proliferation in IPEC-J2 Cells Challenged with ETEC K88 by Inhibiting the Akt Signaling Pathway.
Article in Probiotics and antimicrobial proteins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Time-Resolved Epithelial Responses to ETEC-K88 Reveal Tryptophan-Linked Protection in IPEC-J2 Cells and Strain-Specific Intestinal Injury in Mice.Animals : an open access journal from MDPI · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Porcine β-defensin 2 (pBD2) is an antimicrobial peptide with both antibacterial and immunomodulatory activities and plays an important role against pathogens. Our previous results suggested that pBD2 might exert its protective effects against E. coli by regulating cell apoptosis and proliferation through the Akt signaling pathway. However, the specific roles and underlying mechanisms of pBD2 in regulating these cellular processes remain unclear. In this study, porcine intestinal epithelial cells (IPEC-J2) were treated with pBD2 in the presence of Enterotoxigenic E. coli (ETEC) K88 challenge. pBD2 inhibited ETEC-induced apoptosis, decreased the levels of cleaved caspase-3 and caspase-9, and restored mitochondrial membrane potential, suggesting that pBD2 inhibited ETEC-induced apoptosis via the intrinsic apoptotic pathway. Moreover, pBD2 restored cell proliferation and attenuated ETEC-induced cell cycle arrest in the G0/G1 phase, and upregulated the expression of proliferation-related genes including CDC25A, CDC6, E2F2 and PCNA. In addition, the results further revealed that pBD2 attenuated cell apoptosis and restored cell proliferation in ETEC K88-infected IPEC-J2 cells by inhibiting the Akt signaling pathway. Our results provide further evidence for the protective effects of pBD2 on intestinal epithelial cells and extend its known biological roles. This study elucidates an anti-apoptotic and pro-proliferative mechanism of pBD2 against ETEC infection and provides insights into its potential application.
Indexed as
Identifiers
42412321What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.